Skip to content

Effects of 25-hydroxyvitamin D on dental implant osseointegration in type 2 diabetes mellitus

Effects of 25-hydroxyvitamin D on dental implant osseointegration in type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230727002
Enrollment
72
Registered
2023-07-27
Start date
2023-06-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes mellitus Vitamin D Insufficiency Type 2 Diabetes mellitus Vitamin D Insufficiency

Interventions

Participants with at least one edentulous site with adequate bone dimensions for dental implant placement. The implant sites are required to have at least 4 months of healing post-extraction, with no
Healthy patients,Type 2 diabetes mellitus with normal serum 25(OH)D level,Type 2 diabetes mellitus with low serum 25(OH)D level

Sponsors

Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Healthy patient or patient diagnosed with type 2 diabetes mellitus with edentulous site with adequate bone dimensions for dental implant placement 2. The implant sites are required to have at least 4 months of healing post-extraction, with no previous ridge augmentation or bone grafting

Exclusion criteria

Exclusion criteria: 1. Systemic diseases that may affect wound healing 2. Cancer 3. Bone metabolic disease such as osteoporosis 4. Under treatment using bisphosphonate 5. Regular use of medications that could affect healing 6. Irradiation in head and neck area 7. Untreated periodontal disease 8. Smoking habit 9. Pregnancy or lactation, planned pregnancy 10. Immunocompromised or under immunosuppressive drug treatment 11. Addiction to alcohol or drugs 12. History of kidney stones 13. Abnormal sensitivity to vitamin D or hypervitaminosis D

Design outcomes

Primary

MeasureTime frame
Marginal bone loss at 1,3,6,9 and 12 months follow-up mm

Secondary

MeasureTime frame
Implant stability at 3 months follow-up ISQ value,Bone-related biological marker and inflammatory cytokines 1,2,3,6 and 12 months follow-up pg/ml

Countries

Thailand

Contacts

Public ContactPichchaporn Ruerattanawong

Chulalongkorn University

mine.pichchaporn@gmail.com022188532

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026